Saturday, June 10, 2023

Canada’s Politics and Government News Source Since 1989

Saturday, June 10, 2023 | Latest Paper

TRENDING:

Ongoing uncertainty about prices will deter new drug launches in Canada

Further delays in access or complete denials of access to innovative drugs will hurt even more Canadians with unmet or poorly met health needs that could be helped by these medicines.

Opinion
BY NIGEL RAWSON AND BRETT SKINNER
September 7, 2022

Opinion | BY NIGEL RAWSON AND BRETT SKINNER | September 7, 2022

See all stories BY NIGEL RAWSON AND BRETT SKINNER

More Opinion

To stabilize Canada’s economy, start with a guaranteed liveable income

OpinionBY SENATOR KIM PATE

Canada is ready for open finance and it’s time the government deliver

OpinionBY STEVE BOMS

Here come the climate-aligned finance firefighters

OpinionBY INDEPENDENT SENATOR ROSA GALVEZ

On World Ocean Day, let’s celebrate the thing that connects us all

OpinionBY LOUIE PORTA

Bill C-27 sacrifices consumer privacy for business innovations

OpinionBY YUKA SAI

Related Stories

Is drug price policy evidence-based or evidence-deficient?

OpinionBY BRETT SKINNER

PMPRB’s new regulations could be Canada’s monkey’s paw

Time for the PMPRB to go

OpinionBY NIGEL RAWSON AND BRETT SKINNER

Don’t let the next pandemic meet this pharmaceutical sector

OpinionBY CHUKWUNONSO NWABUFO

Meanwhile, back in the pharma wars

OpinionBY LES WHITTINGTON